CompletedNCT04417712
Lifetech KONAR MFO Post-Market Clinical Follow-Up Study
Studying Rare congenital anomaly of ventricular septum
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Principal Investigator
- Stephan Schubert, LPC, LMFTHeart- and Diabetescenter NRW
- Intervention
- KONAR-MF™ VSD Occluder(device)
- Enrollment
- 40 enrolled
- Eligibility
- All sexes
- Timeline
- 2019 – 2023
Study locations (4)
- 103 - Herz- und Diabeteszentrum NRW / Heart and Diabetes Center NRW, Bad Oeynhausen, Germany
- 101 - Deutsches Herzzentrum der Charité/ German Heart Institute Berlin, Berlin, Germany
- 102 - Deutsches Herzzentrum München/ German Heartcenter Munich, Munich, Germany
- IRCCS Policlinico San Donato, Milan, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04417712 on ClinicalTrials.govOther trials for Rare congenital anomaly of ventricular septum
Additional recruiting or active studies for the same condition.
See all trials for Rare congenital anomaly of ventricular septum →